Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.
It has been previously reported that N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP), which represents the minimal structure that can substitute for mycobacteria in Freund complete adjuvant, activated macrophages in vitro and in vivo. In the present study we show that, in contrast to MDP, the nonadjuvant MDP(DD) stereoisomer has no effect on cytostatic activity of thioglycolate-induced macrophages as measured by uptake of [3H]thymidine. However, surprisingly, after conjugation to an inert carrier, multi-poly(DL-alanyl)-poly(L-lysine), this compound activates macrophages in vitro and becomes at least as effective as MDP. It has also been shown in other studies that after conjugation MDP(DD) remained devoid of antigenicity and of adjuvant activity although such a conjugate could increase resistance to infection. It, therefore, appears that there exists no correlation between the structure required for adjuvant activity and the structure required for macrophage activation or for enhancement of nonspecific immunity.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D006020:Glycopeptides / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins; D008264:Macrophages / Q000187:drug effects / Q000502:physiology*; D012515:Mast-Cell Sarcoma; D051379:Mice; D010455:Peptides / Q000494:pharmacology*; D013237:Stereoisomerism
D000276:Adjuvants, Immunologic; D006020:Glycopeptides; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C022266:poly(Ala)-poly(Lys); D000119:Acetylmuramyl-Alanyl-Isoglutamine